Michael O’Dwyer

Michael O’Dwyer

Company: ONK Therapeutics

Job title: Chief Scientific Officer

Seminars:

Harnessing CRISPR to Knock Out Checkpoint Inhibitors to Enhance CAR-NK Function 11:30 am

Read more

day: Focus Day Track 2

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.